Mantle Cell Lymphoma (MCL) Completed Phase 1 Trials for Talazoparib (DB11760)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01399840Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological MalignanciesTreatment